Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Deshayes

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Annals of Translational Medicine|April 3, 2023
Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?Caterina Cusumano, Emmanuel Deshayes, Boris Guiu, et al.
European Radiology|January 20, 2017
Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant functionBoris Guiu, François Quenet, Laure Escal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized MedicineKévin Hebert, Lore Santoro, Maeva Monnier, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|May 12, 2017
SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniquesOlivier Riou, Carmen Llacer Moscardo, Pascal Fenoglietto, et al.
Molecular Therapy Oncolytics|December 2, 2021
Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapyJin Meng, Emmanuel Deshayes, Li Zhang, et al.
Hepatobiliary Surgery and Nutrition|November 9, 2020
Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changesBoris Guiu, François Quenet, Fabrizio Panaro, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 14, 2018
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC StudyEmmanuel Deshayes, Hélène de Forges, Julien Fraisse, et al.
Medical Physics|July 8, 2020
Comparison of commercial dosimetric software platforms in patients treated with <sup>177</sup> Lu-DOTATATE for peptide receptor radionuclide therapyErick Mora-Ramirez, Lore Santoro, Emmanuelle Cassol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
OpenDose3D: A Free, Open-Source Clinical Dosimetry Software for Patient-Specific DosimetryJosé-Alejandro Fragoso-Negrín, Alex Vergara-Gil, Assyifa Rahman Hakim, et al.
The Oncologist|June 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO studyJean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Annals of Translational Medicine|April 3, 2023
Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?Caterina Cusumano, Emmanuel Deshayes, Boris Guiu, et al.
European Radiology|January 20, 2017
Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant functionBoris Guiu, François Quenet, Laure Escal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized MedicineKévin Hebert, Lore Santoro, Maeva Monnier, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|May 12, 2017
SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniquesOlivier Riou, Carmen Llacer Moscardo, Pascal Fenoglietto, et al.
Molecular Therapy Oncolytics|December 2, 2021
Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapyJin Meng, Emmanuel Deshayes, Li Zhang, et al.
Hepatobiliary Surgery and Nutrition|November 9, 2020
Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changesBoris Guiu, François Quenet, Fabrizio Panaro, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 14, 2018
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC StudyEmmanuel Deshayes, Hélène de Forges, Julien Fraisse, et al.
Medical Physics|July 8, 2020
Comparison of commercial dosimetric software platforms in patients treated with <sup>177</sup> Lu-DOTATATE for peptide receptor radionuclide therapyErick Mora-Ramirez, Lore Santoro, Emmanuelle Cassol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
OpenDose3D: A Free, Open-Source Clinical Dosimetry Software for Patient-Specific DosimetryJosé-Alejandro Fragoso-Negrín, Alex Vergara-Gil, Assyifa Rahman Hakim, et al.
The Oncologist|June 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO studyJean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier, et al.
Pageof 8